{"id":62813,"date":"2026-03-19T13:02:23","date_gmt":"2026-03-19T12:02:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/"},"modified":"2026-03-19T13:02:23","modified_gmt":"2026-03-19T12:02:23","slug":"lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/","title":{"rendered":"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites"},"content":{"rendered":"
\n

\n\u2014<\/i> $9M<\/i> Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid, and Oral Solid Dose Capacity \u2014<\/i><\/p>\n

\n\u2014<\/i> Enhancements Strengthen Domestic Supply Chains for Finished Dose Manufacturing, Complementing Extensive API Sourcing and Analytical Testing Services \u2014<\/i><\/p>\n

BOCA RATON, Fla.–(BUSINESS WIRE)–#505b2<\/a>–LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and CDMO services for the full drug product lifecycle, today announced the second phase of its CDMO growth strategy, committing an additional $9 million to its facilities in Rosenberg, Texas, and Colorado Springs, Colorado. The investment follows the company\u2019s previously announced $6 million expansion<\/a> in Rosenberg in 2025 and is designed to increase commercial capacity, expand R&D capabilities, and support continued demand for U.S.-based drug product manufacturing.<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe Texas facility enhancements include a $4 million investment to expand commercial-scale manufacturing suites for suppositories in response to increasing customer and market demand, including growth in women\u2019s health products. The upgrades also expand R&D capabilities to support formulation and scale-up for suppositories, solutions, suspensions, and semi-solids. The Rosenberg site will remain fully operational throughout construction, with upgrades already underway.<\/p>\n

\nIn Colorado Springs, LGM Pharma will invest $5 million to expand commercial manufacturing capacity for niche, high-value oral solid dose (OSD) products<\/a>, including orally disintegrating tablets (ODTs). The facility has served as the company\u2019s center of excellence for OSD development. The expansion, planned for completion this year, will support growing demand for domestic manufacturing. In 2024, the global OSD CDMO market was valued at $43.65 billion, with North America accounting for approximately 40.5% of global OSD pharmaceutical manufacturing activity.1,2<\/sup><\/p>\n

\n\u201cThese multi-site investments totaling $15 million reflect our continued commitment to strengthening pharmaceutical supply chains in the United States,\u201d said Prasad Raje, Chief Executive Officer of LGM Pharma. \u201cToday\u2019s pharma companies need partners that are both resilient and integrated across the full product lifecycle. By reinforcing domestic drug product manufacturing at the downstream end of the supply chain, closer to end markets, and leveraging our global API sourcing capabilities upstream, we create a balanced end-to-end model. This gives customers greater control and visibility as they move products from development to commercialization.\u201d<\/p>\n

\nEarlier in the supply chain, at the drug substance stage, LGM Pharma supports 505(b)(2), NDA, and ANDA programs through a global network of more than 220 pre-qualified API manufacturers. By combining global drug substance sourcing<\/a> with expanded U.S. finished dose development and manufacturing, the company provides integrated support across the full drug product lifecycle.<\/p>\n

\nHamilton Lenox, Chief Commercial Officer of LGM Pharma, said the company\u2019s prior Rosenberg upgrades from Phase I of the expansion, including implementation of enhanced track-and-trace serialization systems and increased production volumes, are now complete. \u201cWe are executing this next phase of expansion while keeping both facilities fully operational,\u201d Lenox said. \u201cOur teams are experienced in managing complex upgrades without sacrificing quality or disrupting customer supply, which remain our top operational priorities. Rather than overextending in a single phase, we are executing these enhancements incrementally to expand capabilities and capacity while ensuring operational continuity. This approach allows us to strengthen infrastructure, support customer growth, and scale in response to market demand.\u201d<\/p>\n

\nCompanies developing 505(b)(2), NDA, or ANDA products, as well as those with commercial branded or generic portfolios, are encouraged to explore LGM Pharma\u2019s API sourcing and expanded drug product manufacturing capabilities by visiting LGMPharma.com<\/a> or meeting with company executives at DCAT Week<\/a>, March 23-26, 2026, in New York City.<\/p>\n

\nReferences:<\/p>\n

    \n
  1. \nGrand View Research, \u201cOral Solid Dosage CDMO Market Size, Share & Trends Analysis Report,\u201d<\/i> [March 2024].<\/li>\n
  2. \nPersistence Market Research, \u201cOral Solid Dosage Contract Manufacturing Market,\u201d<\/i> [May 2023].<\/li>\n<\/ol>\n

    \nAbout LGM Pharma<\/b><\/p>\n

    \nLGM Pharma is a leading contract development and manufacturing organization (CDMO) providing comprehensive Active Pharmaceutical Ingredient (API) sourcing, drug product CDMO services, and contract analytical testing services to the pharmaceutical, biotechnology, and compounding pharmacy industries. LGM Pharma assists clients in managing all phases of the drug product development process, from API sourcing through to drug product commercialization. LGM Pharma\u2019s extensive global network of qualified API partners enables clients to optimize supply chain management and distribution. Services include API sourcing and procurement, formulation development, drug product manufacturing, analytical method development, method and process validation, ANDA\/NDA submission, stability studies, and raw material and finished product testing and packaging. LGM Pharma is committed to quality and has a long-established positive regulatory track record, providing expert regulatory and market intelligence services to its clients. The company is focused on customer service and customized solutions, providing clients with a comprehensive U.S.-based manufacturing solution that reduces risk, increases efficiency, and accelerates the path to commercialization. For more information, visit LGMPharma.com<\/a>.<\/p>\n

    Contacts<\/b> <\/p>\n

    \nMedia Contact:<\/b><\/p>\n

    \nCharya Wickremasinghe, Ph.D.
    \n
    Brandwidth Solutions LLC
    \n
    cwickremasinghe@brandwidthsolutions.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

    \u2014 $9M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid, and Oral Solid Dose Capacity \u2014 \u2014 Enhancements Strengthen Domestic Supply Chains for Finished Dose Manufacturing, Complementing Extensive API Sourcing and Analytical Testing Services \u2014 BOCA RATON, Fla.–(BUSINESS WIRE)–#505b2–LGM Pharma, a leading provider of … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-62813","6":"format-standard","7":"category-industry"},"yoast_head":"\nLGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"\u2014 $9M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid, and Oral Solid Dose Capacity \u2014 \u2014 Enhancements Strengthen Domestic Supply Chains for Finished Dose Manufacturing, Complementing Extensive API Sourcing and Analytical Testing Services \u2014 BOCA RATON, Fla.–(BUSINESS WIRE)–#505b2–LGM Pharma, a leading provider of ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-19T12:02:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20260319065768\/en\/2741205\/22\/LGM_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites\",\"datePublished\":\"2026-03-19T12:02:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/\"},\"wordCount\":801,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260319065768\\\/en\\\/2741205\\\/22\\\/LGM_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/\",\"name\":\"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260319065768\\\/en\\\/2741205\\\/22\\\/LGM_Logo.jpg\",\"datePublished\":\"2026-03-19T12:02:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260319065768\\\/en\\\/2741205\\\/22\\\/LGM_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20260319065768\\\/en\\\/2741205\\\/22\\\/LGM_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/","og_locale":"en_US","og_type":"article","og_title":"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites - Pharma Trend","og_description":"\u2014 $9M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid, and Oral Solid Dose Capacity \u2014 \u2014 Enhancements Strengthen Domestic Supply Chains for Finished Dose Manufacturing, Complementing Extensive API Sourcing and Analytical Testing Services \u2014 BOCA RATON, Fla.–(BUSINESS WIRE)–#505b2–LGM Pharma, a leading provider of ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/","og_site_name":"Pharma Trend","article_published_time":"2026-03-19T12:02:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20260319065768\/en\/2741205\/22\/LGM_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites","datePublished":"2026-03-19T12:02:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/"},"wordCount":801,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260319065768\/en\/2741205\/22\/LGM_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/","url":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/","name":"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20260319065768\/en\/2741205\/22\/LGM_Logo.jpg","datePublished":"2026-03-19T12:02:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20260319065768\/en\/2741205\/22\/LGM_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20260319065768\/en\/2741205\/22\/LGM_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/lgm-pharma-expands-u-s-manufacturing-bringing-total-investment-to-15m-across-texas-and-colorado-sites\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62813","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=62813"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/62813\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=62813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=62813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=62813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}